Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cardiac and pulmonary involvement in scleroderma].

David Launay1, Eric Hachulla

  • 1Service de médecine interne CHRU-Hôpital Claude-Huriez 59037 Lille.

La Revue Du Praticien
|January 21, 2003
PubMed
Summary

Systemic sclerosis can cause severe heart and lung complications, often without symptoms. Early and regular screening for these issues is crucial for timely intervention and improved outcomes in patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of markers of primary aldosteronism in systemic sclerosis and their relationships with renal and cardiovascular outcomes.

RMD open·2026
Same author

Clinical, biological and cytometric characteristics of two patients with a homozygous A91V<i>PRF1</i> mutation.

Clinical & translational immunology·2026
Same author

Occupational category, job type, and sarcoidosis: Findings from a French multicenter study.

Pulmonology·2026
Same author

The IL-10/IL-6 Ratio and the Risk Score: Two Cytokines-Based Predictors for Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Adults (M-HLHa).

American journal of hematology·2026
Same author

Intensive care admissions for severe immune-related adverse events associated with immune checkpoint inhibitor therapy: a 10-year cohort study.

Journal of critical care·2026
Same author

Factors associated with variations in the 6-minute walk distance during the follow-up of patients with systemic sclerosis.

Arthritis research & therapy·2026

Area of Science:

  • Rheumatology
  • Cardiology
  • Pulmonology

Context:

  • Systemic sclerosis is a connective tissue disease impacting multiple organs.
  • Cardiopulmonary complications significantly contribute to mortality in systemic sclerosis.
  • Clinical manifestations often appear late, necessitating proactive screening.

Purpose:

  • To highlight the importance of systematic screening for cardiac and pulmonary complications in systemic sclerosis.
  • To outline diagnostic methods for heart involvement and pulmonary hypertension.
  • To discuss the diagnostic approach for chronic pulmonary interstitial fibrosis.

Summary:

  • Systemic sclerosis involves microvascular damage and fibrosis affecting the skin, lungs, heart, and gastrointestinal tract.
  • Heart complications include cardiomyopathy, pericarditis, arrhythmias, and conduction abnormalities.
  • Pulmonary hypertension can arise from direct pulmonary artery involvement or secondary to lung fibrosis.
  • Chronic pulmonary interstitial fibrosis is a common lung manifestation, diagnosed via high-resolution computed tomography.
  • Screening via Doppler echocardiography and pulmonary function tests is recommended, with right heart catheterization for diagnosis.

Impact:

  • Emphasizes the need for early detection of subclinical cardiac and pulmonary issues in systemic sclerosis.
  • Guides clinical practice towards systematic and repeated screening protocols.
  • Informs treatment strategies, suggesting immunosuppressants for severe, progressive lung disease.

Related Experiment Videos